( 12 ) United States Patent

Total Page:16

File Type:pdf, Size:1020Kb

( 12 ) United States Patent US009963446B2 (12 ) United States Patent ( 10 ) Patent No. : US 9 ,963 , 446 B2 Burch et al. ( 45) Date of Patent: * May 8 , 2018 ( 54 ) OXEPAN - 2 - YL - PYRAZOL - 4 - YL 6 ,395 , 916 B1 5 /2002 Buchwald et al . HETEROCYCLYL - CARBOXAMIDE 6 , 946, 560 B2 9 / 2005 Buchwald et al. 7 , 026 , 498 B2 4 /2006 Buchwald et al . COMPOUNDS AND METHODS OF USE 7 , 223 , 879 B2 5 / 2007 Buchwald et al . 7 ,247 , 731 B2 7 / 2007 Buchwald et al . ( 71 ) Applicant: Genentech , Inc. , South San Francisco , 7 , 329, 758 B1 2 / 2008 Grubbs et al. CA (US ) 7 ,560 , 582 B2 . 7 / 2009 Buchwald et al. 7 , 858 ,784 B2 12 / 2010 Buchwald et al . (72 ) Inventors : Jason Burch , Pointe - Claire (CA ) ; 8 , 318 ,723 B2 * 11/ 2012 Mao CO7D 213/ 74 Huifen Chen , Burlingame, CA (US ) ; 514 /217 . 05 9 , 328 , 106 B2 * 5 / 2016 Burch .. .. .. .. .. .. .. C07D 417 / 14 Xiaojing Wang, Foster City , CA (US ) 2012 / 0225062 A1 9 / 2012 Burger et al . ( 73 ) Assignee: Genentech , Inc. , South San Francisco , 2013 /0079321 A1 3 /2013 Hodges et al . CA (US ) FOREIGN PATENT DOCUMENTS ( * ) Notice : Subject to any disclaimer, the term of this Wo 1996 /015111 Al 5 / 1996 patent is extended or adjusted under 35 WO 2007 / 044515 AL 4 / 2007 U . S .C . 154 ( b ) by 0 days . days . WO 2007 /099326 AL 9 /2007 WO 2011 / 124580 A 10 / 2011 This patent is subject to a terminal dis wo 2012 /004217 AL 1 / 2012 claimer . ( Continued ) (21 ) Appl. No. : 15 /266 , 243 OTHER PUBLICATIONS International Search Report issued in International Application No . ( 22) Filed : Sep . 15 , 2016 PCT/ EP2015 / 055596 , dated May 27, 2015 , in 4 pages. Written Opinion of the International Searching Authority issued in (65 ) Prior Publication Data International Application No. PCT/ EP2015 /055596 , dated May 27 , US 2017 /0001997 A1 Jan . 5 , 2017 2015 , in 7 pages. ( Author Not Identified ) Beilsteins Handbuch Der Organischen Related U . S . Application Data Chemie ( Table of Contents , total in 8 pages ), Prager et al ., 4th edition , Berlin : Julius Springer, vol. 2 ( 1920 ) . (63 ) Continuation of application No . (Author Not Identified ) Chiral Liquid Chromatography ( Table of PCT/ EP2015 / 055596 , filed on Mar. 18 , 2015 . Contents , total in 9 pages ), W . J . Lough , Glasgow : Blackie Academic & Professional ( 1989 ) . Provisional application No . 61 / 954 ,752 , filed on Mar. (Author Not Identified ) Comprehensive Heterocyclic Chemistry II (60 ) ( Table of Contents , in 4 pages ) , Katritzky et al ., Oxford , 18 , 2014 . UK :Elsevier Science Ltd . , vol. 3 ( 1996 ) . ( Author Not Identified ) Drug Stereochemistry : Analytical Methods (51 ) Int . CI. and Pharmacology ( Table of Contents only , in 5 pages ) , Irving W . C07D 417 / 14 ( 2006 .01 ) Wainer , Second edition , New York :Marcel Dekker , Inc . ( 1993 ) . A61K 31/ 427 ( 2006 . 01 ) (Continued ) A61K 31 /4439 ( 2006 .01 ) A61K 31 /4709 ( 2006 . 01 ) Primary Examiner — Yevgeny Valenrod A61K 31/ 497 ( 2006 .01 ) (74 ) Attorney , Agent, or Firm — Brian L . Buckwalter A61K 31/ 4985 ( 2006 . 01 ) (57 ) ABSTRACT A61K 31 /06 ( 2006 .01 ) Oxepan - 2 - yl pyrazol- 4 - yl- heterocyclyl - carboxamide com CO7D 487 /04 ( 2006 . 01 ) pounds of Formula 1 , including stereoisomers , geometric isomers , tautomers , and pharmaceutically acceptable salts A61K 45 / 06 ( 2006 . 01) thereof, wherein X is thiazolyl, pyrazinyl , pyridinyl, or (52 ) U . S . CI. pyrimidinyl, are useful for inhibiting Pim kinase , and for CPC . .. .. .. C07 417 / 14 (2013 .01 ) ; A61K 31 /427 treating disorders such as cancer mediated by Pim kinase . ( 2013 .01 ) ; A61K 31 /4439 ( 2013 . 01 ) ; A61K Methods of using compounds of Formula I for in vitro , in 31/ 4709 ( 2013 .01 ) ; A61K 31/ 497 ( 2013 .01 ) ; situ , and in vivo diagnosis , prevention or treatment of such A61K 31/ 4985 ( 2013 .01 ) ; A61K 45 / 06 disorders in mammalian cells , or associated pathological (2013 .01 ); C07D 487/ 04 ( 2013 .01 ) conditions, are disclosed . (58 ) Field of Classification Search CPC . .. .. .. .. .. A61K 31/ 427 ; A61K 31 /4439 ; A61K 31/ 4709 ; A61K 31 /497 ; A61K 31 / 4985 ; A61K 45 /06 ; CO7D 417 / 14 ; C07D 487 / 04 USPC . .. .. .. .. .. .. .. .. 514 / 249 RI See application file for complete search history . ( 56 ) References Cited U . S . PATENT DOCUMENTS NH 3 ,773 , 919 A 11/ 1973 Boswell et al . 07x 6 , 111, 121 A 8 / 2000 Grubbs et al. 6 , 307 ,087 B1 10 / 2001 Buchwald et al. 21 Claims, 6 Drawing Sheets US 9 , 963 ,446 B2 Page 2 References Cited De Bruin et al ., “ Anti -HERG Activity and the Risk of Drug - Induced ( 56 ) Arrhythmias and Sudden Death ” , European Heart Journal, 26 :590 597 (2005 ) . FOREIGN PATENT DOCUMENTS Dhanasekaran et al ., “ Delineation of prognostic biomarkers in wo 2013 /045461 AL 4 / 2013 prostate cancer ” , Nature , 412 (6849 ) :822 - 826 ( Aug . 23 , 2001 ) . WO 2014 / 048939 AL 4 / 2014 Eliel et al. , Stereochemistry of Organic Compounds, “ 7 - 3 . Chemical Separation of Enantiomers Via Diastereomers ” , New York : John Wiley & Sons, Inc. , 322 -381 ( 1994 ) . OTHER PUBLICATIONS Ellwood - Yen et al ., “ Myc -driven murine prostate cancer shares (Author Not Identified ) Remington ' s Pharmaceutical Sciences molecular features with human prostate tumors ” , Cancer Cell, ( Table of Contents , total in 4 pages) , Osol et al. , 16th edition , 4 ( 3 ) : 223 - 238 (Sep . 2003 ) . Easton , Pennsylvania :Mack Publishing Company ( 1980 ) . Emmons et al. , The Chemistry of Heterocyclic Compounds, A ( Author Not Identified ) Remington ' s Pharmaceutical Sciences Series of Monographs ( Table of Contents , total in 14 pages ) , ( Table of Contents , total in 6 pages ), Osol et al. , 15th edition , Weissberger, New York , NY, USA : Interscience Publishers , Inc ., vol. Easton , PA :Mack Publishing Company ( 1975 ) . 19 ( 1964 ) . ( Author Not Identified ) , “ International Union of Pure and Applied Ferroni et al . , " Cyclic Guanidines : Synthesis and Antiplatelet Activ Chemistry ” , Journal of The American Chemical Society , 82 : 5566 ity of 4 ,6 , 7 , 8 - Tetrahydro - 1H - imidazo [ 1 , 2 - a ]pyrazolo [ 3 , 4 5572 ( 1960 ) . d ]pyrimidin - 7 -ones and 1 , 4 , 6 , 7 , 8 , 9 -Hexahydropyrazolo Adam et al. , “ Targeting PIM Kinases Impairs Survival of [ 3 ', 4 ": 4 , 5 ]pyrimido [ 2 , 1 - c ] [ 1 , 2 , 4 ] triazin - 7 - ones ” , Arzneim . - Forsch ./ Hematopoietic Cells Transformed by Kinase Inhibitor - Sensitive and Drug Res , 40 :1328 - 1331 (1990 ) . Kinase Inhibitor -Resistant Forms of Fms- Like Tyrosine Kinase 3 Fox et al . , “ The Serine / Threonine Kinase Pim - 2 is a Transcription and BCR /ABL ” , Cancer Res , 66 ( 7 ) : 3828 - 3835 ( Apr. 2006 ) . ally Regulated Apoptotic Inhibitor” , Genes & Development , Aho et al ., “ Expression of Human pim Family Genes is Selectively 17 : 1841 - 1854 (2003 ) . up - regulated by Cytokines Promoting T Helper Type 1 , but not T Fujii et al. , " Aberrant Expression of Serine / Threonine Kinase Pim - 3 Helper Type 2 , Cell Differentiation ” , Immunology , 116 : 82 - 88 in Hepatocellular Carcinoma Development and its Role in the ( 2005 ) . Proliferation of Human Hepatoma Cell Lines ” , International Journal Aho et al ., “ Pim - 1 Kinase Promotes Inactivation of the Pro of Cancer, 114 :209 - 218 (2005 ) . Apoptotic Bad Protein by Phosphorylating it on the Ser112 Gate Green et al. , Protective Groups in Organic Synthesis ( Table of keeper Site ” , FEBS Letters, 571: 43 -49 ( 2004 ) . Contents only , in 4 pages ), Second edition , New York : John Wiley & Aksoy et al ., “ Self -Renewal of Murine Embryonic Stem Cells is Sons , Inc . ( 1991 ) . Supported by the Serine / Threonine Kinases Pim - 1 and Pim - 3 ” , Greene et al. Protective Groups in Organic Syntheis ( Table of Stem Cells, 25 :2996 -3004 ( 2007 ) . Contents , in 4 pages) , 3rd edition , New York , NY, USA : John Wiley Allen et al . , " Pim - 2 Transgene Induces Lymphoid Tumors , Exhib & Sons , Inc . ( 1999 ) . iting Potent Synergy with c -myc ” , Oncogene, 15 : 1133 - 1141 ( 1997 ) . Greenstein et al. , “ Characterization of the MM . 1 Human Multiple Amson et al. , “ The Human Protooncogene Product p33pim is Myeloma (MM ) Cell Liness : A Model System to Elucidate the Expressed During Fetal Hematopoiesis and in Diverse Leukemias” , Characteristics , Behavior, and Signaling of Steroid -Sensitive and Proc . Natl . Acad . Sci . USA , 86 : 8857 -8861 ( 1989 ) . Resistant MM Cells” , Experimental Hematology , 31 : 271 - 282 Bachmann et al. , “ The Oncogenic Serine / Threonine Kinase Pim - 1 Directly Phosphorylates and Activates the G2 / M Specific ( 2003 ) . Phosphatase Cdc25C ” , The International Journal of Biochemistry & Hammerman et al. , “ Pim and Akt oncogenes are independent Cell Biology 38 :430 -443 ( 2006 ) . regulators of hematopoietic cell growth and survival” , Blood , Barnes et al . , The Chemistry of Heterocyclic Compounds, A Series 105 ( 11 ) : 4477 -4483 ( 2005 ) . of Monographs ( Table of Contents, total in 8 pages ) , Weissberger , Hedley et al. , “ The Genetic Basis of Long QT and Short QT New York , NY, USA : Interscience Publishers , Inc. , vol. 14 ( 1960 ) . Syndromes : A Mutation Update ” , Human Mutation , 30 ( 11 ) : 1486 Billingsley et al . , “ Pallaium - Catalyzed Borylation of Aryl Chlo 1511 (2009 ) . rides: Scope , Applications, and Computational Studies ” , Hirano et al ., “ Roles of STAT3 in Mediating the Cell Growth , Angewandte Chemie Int. Ed , . 46 :5359 - 5363 (2007 ) . Differentiation and Survival Signals Relayed Through the IL - 6 Biscoe et al. , “ A New Class of Easily Activated Palladium Family of Cytokine Receptors ”
Recommended publications
  • Inventory Size (Ml Or G) 103220 Dimethyl Sulfate 77-78-1 500 Ml
    Inventory Bottle Size Number Name CAS# (mL or g) Room # Location 103220 Dimethyl sulfate 77-78-1 500 ml 3222 A-1 Benzonitrile 100-47-0 100ml 3222 A-1 Tin(IV)chloride 1.0 M in DCM 7676-78-8 100ml 3222 A-1 103713 Acetic Anhydride 108-24-7 500ml 3222 A2 103714 Sulfuric acid, fuming 9014-95-7 500g 3222 A2 103723 Phosphorus tribromide 7789-60-8 100g 3222 A2 103724 Trifluoroacetic acid 76-05-1 100g 3222 A2 101342 Succinyl chloride 543-20-4 3222 A2 100069 Chloroacetyl chloride 79-04-9 100ml 3222 A2 10002 Chloroacetyl chloride 79-04-9 100ml 3222 A2 101134 Acetyl chloride 75-36-5 500g 3222 A2 103721 Ethyl chlorooxoacetate 4755-77-5 100g 3222 A2 100423 Titanium(IV) chloride solution 7550-45-0 100ml 3222 A2 103877 Acetic Anhydride 108-24-7 1L 3222 A3 103874 Polyphosphoric acid 8017-16-1 1kg 3222 A3 103695 Chlorosulfonic acid 7790-94-5 100g 3222 A3 103694 Chlorosulfonic acid 7790-94-5 100g 3222 A3 103880 Methanesulfonic acid 75-75-2 500ml 3222 A3 103883 Oxalyl chloride 79-37-8 100ml 3222 A3 103889 Thiodiglycolic acid 123-93-3 500g 3222 A3 103888 Tetrafluoroboric acid 50% 16872-11-0 1L 3222 A3 103886 Tetrafluoroboric acid 50% 16872-11-0 1L 3222 A3 102969 sulfuric acid 7664-93-9 500 mL 2428 A7 102970 hydrochloric acid (37%) 7647-01-0 500 mL 2428 A7 102971 hydrochloric acid (37%) 7647-01-0 500 mL 2428 A7 102973 formic acid (88%) 64-18-6 500 mL 2428 A7 102974 hydrofloric acid (49%) 7664-39-3 500 mL 2428 A7 103320 Ammonium Hydroxide conc.
    [Show full text]
  • Method for Preparing 2,3-Dichloro-1-Propanol and 3-Chloro-1-Propanol
    Europaisches Patentamt 19 European Patent Office Office europeen des brevets © Publication number : 0 579 362 A1 EUROPEAN PATENT APPLICATION © Application number : 93303893.7 © int. ci.5: C07C 31/36, C07C 29/32 @ Date of filing : 19.05.93 © Priority: 13.07.92 JP 184910/92 @ Inventor: Watanabe, Hiroyoshi 18.12.92 JP 338584/92 3-4-1-141, Toriishi Takaishi-shi, Osaka-fu (JP) Inventor : Hayakawa, Fumie @) Date of publication of application : 4-7-3-342, Kamo 19.01.94 Bulletin 94/03 Takaishi-shi, Osaka-fu (JP) © Designated Contracting States : © Representative : Stuart, Ian Alexander et al DE FR GB IT NL MEWBURN ELLIS 2 Cursitor Street London EC4A 1BQ (GB) © Applicant : MITSUI TOATSU CHEMICALS, Inc. 2-5 Kasumigaseki 3-chome Chiyoda-Ku Tokyo 100 (JP) © Method for preparing 2,3-dichloro-1-propanol and 3-chloro-1-propanol. © A method for preparing 2,3-dichloro-l- propanol and 23-chloro-l-propanol is here dis- closed which comprises the step of reacting 1,2-dichloroethane with methanol by irradiation with light in the presence of at least one com- pound selected from europium compounds, samarium compounds and ytterbium com- pounds, and if necessary, in the additional pre- sence of a zeolite. CM CO CO o> ro- ta LU Jouve, 18, rue Saint-Denis, 75001 PARIS 1 EP 0 579 362 A1 2 The present invention relates to a method for pre- As a method to solve these problems, the pres- paring 2,3-dichloro-1-propanol and 3-chloro-1- ent inventor have suggested a method for preparing propanol.
    [Show full text]
  • Brilliant Luminescence of Lanthanide Complexes with C-3V Geometrical Structures
    Title Seven-Coordinate Luminophores: Brilliant Luminescence of Lanthanide Complexes with C-3v Geometrical Structures Yanagisawa, Kei; Nakanishi, Takayuki; Kitagawa, Yuichi; Seki, Tomohiro; Akama, Tomoko; Kobayashi, Masato; Author(s) Taketsugu, Tetsuya; Ito, Hajime; Fushimi, Koji; Hasegawa, Yasuchika European journal of inorganic chemistry(28), 4769-4774 Citation https://doi.org/10.1002/ejic.201500820 Issue Date 2015-10 Doc URL http://hdl.handle.net/2115/62879 This is the peer reviewed version of the following article: European Journal of Inorganic Chemistry 2015(28) 4769- Rights 4774, which has been published in final form at http://doi.org/10.1002/ejic.201500820. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving. Type article (author version) File Information paper.pdf Instructions for use Hokkaido University Collection of Scholarly and Academic Papers : HUSCAP FULL PAPER Seven-Coordinate Luminophores: Brilliant Luminescence of Lanthanide Complexes with C3v Geometrical Structures Kei Yanagisawa,[b] Takayuki Nakanishi,[a] Yuichi Kitagawa,[a] Tomohiro Seki,[a] Tomoko Akama,[c] Masato Kobayashi,[c] Tetsuya Taketsugu,[c] Hajime Ito,[a] Koji Fushimi,[a] Yasuchika Hasegawa*[a] Abstract: Enhanced Luminescence properties of mononuclear detail. Zuo and co-workers studied on seven-coordinate lanthanide complexes with asymmetric seven-coordination structure lanthanide porphyrinate and phthalocyaninate complexes with tripodal phosphine oxide ligand for single-molecule magnet. [6] are reported for the first time. The lanthanide complexes are III III The seven-coordination would be due to the steric hindrance of composed of a lanthanide ion (Eu or Tb ), three tetramethyl macrocyclic molecules. Based on such background, an heptanedionatos and one triphenyl phosphine oxide.
    [Show full text]
  • List of Lists
    United States Office of Solid Waste EPA 550-B-10-001 Environmental Protection and Emergency Response May 2010 Agency www.epa.gov/emergencies LIST OF LISTS Consolidated List of Chemicals Subject to the Emergency Planning and Community Right- To-Know Act (EPCRA), Comprehensive Environmental Response, Compensation and Liability Act (CERCLA) and Section 112(r) of the Clean Air Act • EPCRA Section 302 Extremely Hazardous Substances • CERCLA Hazardous Substances • EPCRA Section 313 Toxic Chemicals • CAA 112(r) Regulated Chemicals For Accidental Release Prevention Office of Emergency Management This page intentionally left blank. TABLE OF CONTENTS Page Introduction................................................................................................................................................ i List of Lists – Conslidated List of Chemicals (by CAS #) Subject to the Emergency Planning and Community Right-to-Know Act (EPCRA), Comprehensive Environmental Response, Compensation and Liability Act (CERCLA) and Section 112(r) of the Clean Air Act ................................................. 1 Appendix A: Alphabetical Listing of Consolidated List ..................................................................... A-1 Appendix B: Radionuclides Listed Under CERCLA .......................................................................... B-1 Appendix C: RCRA Waste Streams and Unlisted Hazardous Wastes................................................ C-1 This page intentionally left blank. LIST OF LISTS Consolidated List of Chemicals
    [Show full text]
  • Draft Screening Assessment for the Challenge
    Screening Assessment for the Challenge Cobalt (Elemental cobalt) Chemical Abstracts Service Registry Number 7440-48-4 Cobalt chloride Chemical Abstracts Service Registry Number 7646-79-9 Sulfuric acid, cobalt (2+) salt (1:1) (Cobalt sulfate) Chemical Abstracts Service Registry Number 10124-43-3 Sulfuric acid, cobalt salt (Cobalt sulfate) Chemical Abstracts Service Registry Number 10393-49-4 Environment Canada Health Canada January 2011 Screening Assessment CAS RN 7440-48-4, 7646-79-9, 10124-43-3, 10393-49-4 Synopsis Pursuant to section 74 of the Canadian Environmental Protection Act, 1999 (CEPA 1999), the Ministers of the Environment and of Health have conducted a screening assessment of elemental cobalt, Chemical Abstracts Service Registry Number (CAS RN) 7440-48-4, cobalt chloride, CAS RN 7646-79-9, and cobalt sulfate, CAS RN 10124-43-3 and CAS RN 10393-49-4. The substances elemental cobalt, cobalt chloride and cobalt sulfate (CAS RN 10124-43-3) were identified in the categorization of the Domestic Substances List as high priorities for action under the Challenge. Elemental cobalt and cobalt sulfate (CAS RN 10124-43-3) were considered to pose greatest potential for exposure of individuals in Canada whereas cobalt chloride was considered to pose intermediate potential for exposure. All of these substances are classified by other agencies on the basis of carcinogenicity. These substances all met the ecological categorization criteria for persistence; cobalt chloride and cobalt sulfate also met the categorization criteria for inherent toxicity to aquatic organisms. Therefore this assessment considers both human health and ecological risks. The substances were assessed together as they generate a common moiety of concern, Co2+, under physiological and environmental conditions, and are thus considered to be toxicologically equivalent.
    [Show full text]
  • Environmental Protection Agency § 302.4
    Environmental Protection Agency § 302.4 State, municipality, commission, polit- ern Marianas, and any other territory ical subdivision of a State, or any or possession over which the United interstate body; States has jurisdiction; and Release means any spilling, leaking, Vessel means every description of pumping, pouring, emitting, emptying, watercraft or other artificial contriv- discharging, injecting, escaping, leach- ance used, or capable of being used, as ing, dumping, or disposing into the en- a means of transportation on water. vironment (including the abandonment or discarding of barrels, containers, [50 FR 13474, Apr. 4, 1985, as amended at 67 FR 45321, July 9, 2002] and other closed receptacles containing any hazardous substance or pollutant § 302.4 Designation of hazardous sub- or contaminant), but excludes: stances. (1) Any release which results in expo- (a) Listed hazardous substances. The sure to persons solely within a work- place, with respect to a claim which elements and compounds and haz- such persons may assert against the ardous wastes appearing in table 302.4 employer of such persons; are designated as hazardous substances (2) Emissions from the engine ex- under section 102(a) of the Act. haust of a motor vehicle, rolling stock, (b) Unlisted hazardous substances. A aircraft, vessel, or pipeline pumping solid waste, as defined in 40 CFR 261.2, station engine; which is not excluded from regulation (3) Release of source, byproduct, or as a hazardous waste under 40 CFR special nuclear material from a nuclear 261.4(b), is a hazardous substance under incident, as those terms are defined in section 101(14) of the Act if it exhibits the Atomic Energy Act of 1954, if such any of the characteristics identified in release is subject to requirements with 40 CFR 261.20 through 261.24.
    [Show full text]
  • Knudsen Effusion Mass Spectrometry Studies on Metal Halides Performed in 1990-2014
    The Pharmaceutical and Chemical Journal, 2016, 3(1):68-93 Available online www.tpcj.org ISSN: 2349-7092 Review Article CODEN(USA): PCJHBA Knudsen effusion mass spectrometry studies on metal halides performed in 1990-2014 Kamila Armatys1*, Miroslaw Miller2 1Bundesanstalt für Materialforschung und-prüfung (BAM), Richard-Willstätter-Str. Berlin, Germany 2International Laboratory of High Magnetic Fields and Low Temperatures, Gajowicka, Wrocław, Poland Abstract Investigations on metal halide systems carried out by Knudsen effusion mass spectrometry in the period 1990-2014 are reviewed in the present paper.163 original papers were published focused on metal halides showing still considerable activity in this area. The fundamentals of the Knudsen effusion mass spectrometry method and thermodynamic background of the investigation are briefly reported. Data to the system studied, temperature ranges, Knudsen cell materials, vapor species identified in the equilibrium vapors and the thermodynamic properties obtained in the study are presented. The important issues of metal halide vaporization studies are briefly discussed and commented. The studies of the vaporization of metal halogens by Knudsen effusion mass spectrometry aimed firstly atthe determination of gaseous complexes species in the vapor and determination of its thermodynamic data like sublimation enthalpy etc. and secondly at the determination of negative ions formation and various ion-molecule equilibria reactions of metal halide systems. Many of the studied materials have a crucial role for modern technologies, for example metal halide lamps, hot corrosion caused by halide salts, phosphorus recovery technologies or gas assisted separation of lanthanides. The investigation of such systems gives information on mechanisms of vaporization, volatility of the systems under various conditions (temperature, pressure etc.), reactivity, thermal stability, resistance etc.
    [Show full text]
  • Draft Report on Carcinogens Monograph on Antimony Trioxide
    Draft Report on Carcinogens Monograph on Antimony Trioxide Peer-Review Draft November 29, 2017 Office of the Report on Carcinogens Division of the National Toxicology Program National Institute of Environmental Health Sciences U.S. Department of Health and Human Services This information is distributed solely for the purpose of pre-dissemination peer review under applicable information quality guidelines. It has not been formally distributed by the National Toxicology Program. It does not represent and should not be construed to represent any NTP determination or policy. This Page Intentionally Left Blank Peer-Review Draft RoC Monograph on Antimony Trioxide 11/29/17 Foreword The National Toxicology Program (NTP) is an interagency program within the Public Health Service (PHS) of the Department of Health and Human Services (HHS) and is headquartered at the National Institute of Environmental Health Sciences of the National Institutes of Health (NIEHS/NIH). Three agencies contribute resources to the program: NIEHS/NIH, the National Institute for Occupational Safety and Health of the Centers for Disease Control and Prevention (NIOSH/CDC), and the National Center for Toxicological Research of the Food and Drug Administration (NCTR/FDA). Established in 1978, the NTP is charged with coordinating toxicological testing activities, strengthening the science base in toxicology, developing and validating improved testing methods, and providing information about potentially toxic substances to health regulatory and research agencies, scientific and medical communities, and the public. The Report on Carcinogens (RoC) is prepared in response to Section 301 of the Public Health Service Act as amended. The RoC contains a list of identified substances (i) that either are known to be human carcinogens or are reasonably anticipated to be human carcinogens and (ii) to which a significant number of persons residing in the United States are exposed.
    [Show full text]
  • 7.88 a Water-Borne Latex Carrying MK-Eufod As a Luminescentt Stain
    UvA-DARE (Digital Academic Repository) Luminescent Lanthanide Complexes: Visible Light Sensitised Red and Near- infrared Luminescence. Werts, M.H.V. Publication date 2000 Link to publication Citation for published version (APA): Werts, M. H. V. (2000). Luminescent Lanthanide Complexes: Visible Light Sensitised Red and Near-infrared Luminescence. General rights It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons). Disclaimer/Complaints regulations If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible. UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl) Download date:08 Oct 2021 Chapterr 7 Interactionss between push-pulll chromophores andd lanthanide (3-diketonates Fromm the near-infrared luminescent complexes described in the previous three chapters we returnn to the visibly emitting europium(HI) complexes, at least during the first part of this chapter.. Accidentally a complex was discovered which produces photosensitised Eu3+ luminescencee upon excitation with visible light. This chapter starts out with a detailed studyy of this complex and similar ones.
    [Show full text]
  • The Electrochemical Synthesis of Europium Boride
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Directory of Open Access Journals Journal of Mining and Metallurgy, 39 (1‡2) B (2003) 251 - 259. THE ELECTROCHEMICAL SYNTHESIS OF EUROPIUM BORIDE G. A. Bukatova*, S. A. Kuznetsov* and M.Gaune-Escard** * Institute of Chemistry and Technology of Rare Elements and Mineral Raw Materials, Kola Science Center, RAS, Fersman St. 26A, 184209 Apatity, Russia (E-mail: [email protected]) ** IUSTI, U.M.R.-C.N.R.S. 6595, Technopole de Chateau Gombert, 5 rue Enrico Fermi, 13453 Marseille Cedex 13, France (Received 20 December 2002; accepted 12 February 2003) Abstract The electroreduction of boron, europium and the electrochemical synthesis of europium boride have been investigated in NaCl-KCl-NaF(10 wt. %) melt on silver and molybdenum electrodes. The parameters of boron reduction in the chloride-fluoride melt have been obtained and the character of its joint deposition with europium has been studied. Keywords: molten salts, electrochemical synthesis, boron, europium 1. Introduction The intensive production of titanium, niobium, tantalum, thorium arouses the necessity of utilization of rare earth metals, accompanying them in mineral raw materials. Modern techniques has high claims to new materials – they should satisfy the set of physical, technological, exploitation characteristics. Europium boride is recognized in metallurgy, electronics, nuclear techniques, etc., due to its advanced elec- trophysical properties combined with a high melting point, excellent corrosion resistance. Electrochemical synthesis in molten salts is a promising method for the rare earth (RE) compounds production [1]. Besides comparative simplicity and relatively low costs, this method allows obtaining of products of high purity and desirable morphology (porousless thin layers or powders with controlled grain size) out of contaminated initial J.
    [Show full text]
  • Information to Users
    INFORMATION TO USERS This manuscript has been reproduced from the microfilm master. UMI films the text directly from the original or copy submitted. Thus, some thesis and dissertation copies are in typewriter face, while others may be from any type of computer printer. The quality of this reproduction is dependent upon the quality of the copy submitted. Broken or indistinct print, colored or poor quality illustrations and photographs, print bleedthrough, substandard margins, and improper alignment can adversely affect reproduction. In the unlikely event that the author did not send UMI a complete manuscript and there are missing pages, these will be noted. Also, if unauthorized copyright material had to be removed, a note will indicate the deletion. Oversize materials (e.g., maps, drawings, charts) are reproduced by sectioning the original, beginning at the upper left-hand corner and continuing from left to right in equal sections with small overlaps. Each original is also photographed in one exposure and is included in reduced form at the back of the book. Photographs included in the original manuscript have been reproduced xerographically in this copy. Higher quality9 "6" black x and white photographic prints are available for any photographs or illustrations appearing in this copy for an additional charge. Contact UMI directly to order. University Microfilms International A Bell & Howell Information Company 300 North Zeeb Road. Ann Arbor, Ml 48106-1346 USA 313/761-4700 800/521-0600 Order Number 9401351 Preparation of ytterbium and europium borides from Yb(II) and Eu(II) boron hydride precursors Salupo, Terese Ann, Ph.D. The Ohio State University, 1993 UMI 300 N.
    [Show full text]
  • I a Database of Produced Water Constituents with Ranking Of
    A Database of Produced Water Constituents with Ranking of Human Health Risk By Sydney M. Joffre B.S. Chemical Engineering, University of Colorado, 2018 B.S. Environmental Engineering, University of Colorado, 2019 A thesis submitted to the Faculty of the Graduate School of the University of Colorado in partial fulfillment of the requirement for the degree Master of Science Department of Civil, Environmental, and Architectural Engineering 2020 Committee Members: Cloelle Danforth Karl Linden James Rosenblum Joseph Ryan i Abstract: Sydney M. Joffre (Master of Science, Civil, Environmental, and Architectural Engineering) A Database of Produced Water Constituents with Ranking of Human Health Risk Thesis Directed by Professor Joseph N. Ryan Produced water is the largest waste stream of upstream oil and gas production in terms of volume. This study aims to address the implications of produced water reuse applications and inadvertent releases. We created a database of compounds identified in produced water from onshore oil and gas operations in North America and developed a prioritization scheme for those chemicals based on potential risk to human health. Through a comprehensive literature review, we found 179 studies that met our inclusion criteria. In total, there were 1,337 chemicals with a Chemical Abstract Service (CAS) number and 41 general water quality parameters (e.g., total dissolved solids, alkalinity) in produced water reported by the studies. We used the database to create a list of unique chemicals that had data available through the U.S. Environmental Protection Agency’s CompTox Dashboard and were in two or more individual samples at concentrations above the method detection limit.
    [Show full text]